'Background' adverse event study will inform global COVID vaccine safety monitoring

COVID vaccine surveillance efforts are a global priority, but safety monitoring for vaccines should not reflect a single population. The largest, most extensive international study of the background rates of adverse events of special interest (AESI) that are being tracked in vaccine surveillance efforts show that adverse event rates vary substantially by age, sex, and method of data capture.